In the coming years, an earthquake is expected near Poltava, which will be dangerous for all of Ukraine – geophysicist
August 5, 2024
Facing up to 3 years in prison: 13 people in Switzerland suspected of mercenary activity on the side of Ukraine
August 5, 2024
The Ministry of Health of Ukraine plans to purchase medicines for cancer patients at prices significantly higher than the market rates, which could lead to losses of over 212 million hryvnias (€4.75 million) from the state budget.
This was reported by the publication Telegraf.
In a statement from the Indian company Euro Lifecare Private Limited, it was indicated that the tender offer for the drug “Everolimus” (10 mg) from Natco Pharma Limited was 182.5 million UAH, while the next lowest offer was 359 million UAH, which could have saved 176.4 million UAH. A similar situation exists with the drug “Everolimus” (5 mg) – the price difference could have saved 35.9 million UAH (€804,090).
The company’s press service stated that in the conditions of war, such actions are true cynicism, and called on law enforcement agencies and the country’s leadership to respond to the situation.
English 
Русский